Join to View Full Profile
550 University BlvdSte 3240Indianapolis, IN 46202
Phone+1 317-944-7744
Fax+1 317-944-7051
Dr. Androphy is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Elliot Androphy, MD, based in Indianapolis, IN, specializes in dermatology and has a notable academic and research background. He completed his dermatology residency at the National Institutes of Health Clinical Center and UPMC Medical Education, following his graduation from the University of Rochester School of Medicine and Dentistry. He served as a professor and vice chair at the University of Massachusetts Medical School and was a professor at Tufts Medical Center. His research interests include molecular biology of papillomaviruses and spinal muscular atrophy , with multiple publications in notable journals. His achievements include being named a Fellow by the American Academy of Microbiology and an AAAS Fellow.
Education & Training
National Institutes of Health Clinical CenterResidency, Dermatology, 1982 - 1986
UPMC Medical EducationResidency, Dermatology, 1980 - 1982
University of Rochester School of Medicine and DentistryClass of 1979
Certifications & Licensure
IN State Medical License 2010 - 2027
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow American Academy of Microbiology, 2022
- CMS Meaningful Use Stage 2 Certification HealthSentry, Cerner Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification Powerchart and Cerner Healthe, Cerner Corporation, 2014-2017
Publications & Presentations
PubMed
- Covalent inhibitors of human papillomavirus type 16 E6 protein restore p53 function and suppress growth of HPV-driven tumors in vivo.Anne Rietz, Lokesh Kumari, Ankeeta Koirala, Stephane Pelletier, Zhijian Lu
Proceedings of the National Academy of Sciences of the United States of America. 2026-06-09 - ZPR1 Is Dispensable for HPV R-Loop Resolution but Regulates Host R-Loop Dynamics.Rylann Moffitt, Steven Brooks, Elliot J Androphy, Marsha DeSmet
Viruses. 2025-11-13 - E2 Tyrosine 102 Regulates MmuPV1 Pathogenesis In Vivo.Jessica Gonzalez, Marsha DeSmet, Kennedy Stoll, Leny Jose, Neil Christensen
Pathogens. 2025-09-11
Press Mentions
Kovina Therapeutics Receives National Cancer Institute Grant to Advance Human Papillomavirus Cancer TreatmentJune 27th, 2022
Grant Announcement: Cure SMA Awards $150,000 Grant to Timra Gilson, Ph.D., Indiana UniversityMarch 5th, 2020
Grant Support
- Small-Molecule Covalent E6 Antagonists for Treatment of HPV InfectionINDIANA UNIVERSITY INDIANAPOLIS2021–2026
- Development of a mouse model to test HPV Antiviral compoundsINDIANA UNIVERSITY INDIANAPOLIS2022–2025
- The COPA vesicle protein and pathogenesis of spinal muscular atrophyINDIANA UNIVERSITY INDIANAPOLIS2013–2025
- Functions Of Papillomavirus E6National Cancer Institute2010–2012
- Small Molecule Inhibitors Of Oncogenic Human PapillomavirusNational Cancer Institute2011
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
